Noda, T.; Kamiya, K.; Hamazaki, N.; Nozaki, K.; Ichikawa, T.; Yamashita, M.; Uchida, S.; Maekawa, E.; Terada, T.; Reed, J.L.;
et al. The Prevalence of Metabolic Dysfunction-Associated Fatty Liver Disease and Its Association with Physical Function and Prognosis in Patients with Acute Coronary Syndrome. J. Clin. Med. 2022, 11, 1847.
https://doi.org/10.3390/jcm11071847
AMA Style
Noda T, Kamiya K, Hamazaki N, Nozaki K, Ichikawa T, Yamashita M, Uchida S, Maekawa E, Terada T, Reed JL,
et al. The Prevalence of Metabolic Dysfunction-Associated Fatty Liver Disease and Its Association with Physical Function and Prognosis in Patients with Acute Coronary Syndrome. Journal of Clinical Medicine. 2022; 11(7):1847.
https://doi.org/10.3390/jcm11071847
Chicago/Turabian Style
Noda, Takumi, Kentaro Kamiya, Nobuaki Hamazaki, Kohei Nozaki, Takafumi Ichikawa, Masashi Yamashita, Shota Uchida, Emi Maekawa, Tasuku Terada, Jennifer L. Reed,
and et al. 2022. "The Prevalence of Metabolic Dysfunction-Associated Fatty Liver Disease and Its Association with Physical Function and Prognosis in Patients with Acute Coronary Syndrome" Journal of Clinical Medicine 11, no. 7: 1847.
https://doi.org/10.3390/jcm11071847
APA Style
Noda, T., Kamiya, K., Hamazaki, N., Nozaki, K., Ichikawa, T., Yamashita, M., Uchida, S., Maekawa, E., Terada, T., Reed, J. L., Yamaoka-Tojo, M., Matsunaga, A., & Ako, J.
(2022). The Prevalence of Metabolic Dysfunction-Associated Fatty Liver Disease and Its Association with Physical Function and Prognosis in Patients with Acute Coronary Syndrome. Journal of Clinical Medicine, 11(7), 1847.
https://doi.org/10.3390/jcm11071847
